| 000 | 01851 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515155431.0 | ||
| 264 | 0 | _c20090330 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1476-0711 | ||
| 024 | 7 |
_a10.1186/1476-0711-8-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdelaal, Amina | |
| 245 | 0 | 0 |
_aGenotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial. _h[electronic resource] |
| 260 |
_bAnnals of clinical microbiology and antimicrobials _cJan 2009 |
||
| 300 |
_a4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aCatalase _xgenetics |
| 650 | 0 | 4 |
_aDNA, Bacterial _xchemistry |
| 650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSequence Analysis, DNA _xmethods |
| 650 | 0 | 4 |
_aTuberculosis _xmicrobiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEl-Ghaffar, Hassan Abd | |
| 700 | 1 | _aZaghloul, Mohammad Hosam Eldeen | |
| 700 | 1 | _aEl Mashad, Noha | |
| 700 | 1 | _aBadran, Ehab | |
| 700 | 1 | _aFathy, Amal | |
| 773 | 0 |
_tAnnals of clinical microbiology and antimicrobials _gvol. 8 _gp. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-0711-8-4 _zAvailable from publisher's website |
| 999 |
_c18628730 _d18628730 |
||